+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

New and emerging drugs for the treatment of acne vulgaris in adolescents



New and emerging drugs for the treatment of acne vulgaris in adolescents



Expert Opinion on PharmacoTherapy 2019: 1-16



Acne vulgaris is the most common skin disease worldwide, yet current treatment options, although effective, are associated with unwanted side effects, chronicity, relapses and recurrences. The adequate control of the four pathogenic mechanisms involved in the appearance of acne lesions is key to treatment success. This paper aims to discuss the novel treatment modalities that have surfaced in consequence of new knowledge obtained in acne pathogenesis. Areas covered: Pathogenic pathways are evaluated and discussed throughout the paper in relation to the mechanisms of action of novel molecules being investigated for the treatment of acne vulgaris. A comprehensive search was made in PubMed and Clinicaltrial.gov using a different combination of keywords, which included acne vulgaris, treatment, therapy, and therapeutic. Expert opinion: In the near future, more effective treatments with less side effects are expected. The use of topical anti-androgens, coenzyme-A carboxylase inhibitors, and insulin growth factor-1inhibitors to control sebum production seem promising. Selective RAR-agonists have the potential of becoming an alternative to the currently available retinoid therapy in the management of infundibular dyskeratosis with a better safety profile. Antibiotic use will probably decline as more effective options for controlling Cutinebacterium acnes colonization and the inflammation cascade emerge.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066569934

Download citation: RISBibTeXText

PMID: 30848961

DOI: 10.1080/14656566.2019.1584182


Related references

Randomized, controlled trial split-faced study of 595-nm pulsed dye laser in the treatment of acne vulgaris and acne erythema in adolescents and early adulthood. International Journal of Dermatology 56(8): 884-888, 2017

Emerging drugs for the treatment of acne. Expert Opinion on Emerging Drugs 20(1): 91-101, 2015

Drugs in the treatment of acne vulgaris. British Medical Journal 2(5162): 1320-1322, 1959

Drugs that are ineffective in the treatment of acne vulgaris. British Journal of Dermatology 108(3): 371-374, 1983

Efficacy and safety of dapsone gel 5% for the treatment of acne vulgaris in adolescents. Cutis 81(2): 171-178, 2008

The pathophysiology of acne vulgaris in children and adolescents, part 2: Tailoring treatment. Cutis 74(3): 189-192, 2004

Type I collagen N-telopeptide changes in adolescents during treatment with isotretinoin for severe acne vulgaris. Hormone Research (Basel) 53(Suppl 2): 129, July, 2000

The efficacy of topical drugs in treatment of noninflammatory acne vulgaris. Georgian Medical News 2011(186): 46-50, 2011

Responsiveness of the Acne-Specific Quality of Life Questionnaire (Acne-QoL) to treatment for acne vulgaris in placebo-controlled clinical trials. Quality of Life Research 11(8): 809-816, 2002

Medication adherence, healthcare costs and utilization associated with acne drugs in Medicaid enrollees with acne vulgaris. American Journal of Clinical Dermatology 14(3): 243-251, 2014

Nonablative radiofrequency for active acne vulgaris: the use of deep dermal heat in the treatment of moderate to severe active acne vulgaris (thermotherapy): a report of 22 patients. Dermatologic Surgery 29(4): 333-9; Discussion 339, 2003

Emerging Therapies for Acne Vulgaris. American Journal of Clinical Dermatology 19(4): 505-516, 2018

The Role of Skin Care as an Integral Component in the Management of Acne Vulgaris: Part 2: Tolerability and Performance of a Designated Skin Care Regimen Using a Foam Wash and Moisturizer SPF 30 in Patients with Acne Vulgaris Undergoing Active Treatment. Journal of Clinical and Aesthetic Dermatology 6(12): 28-36, 2014

Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials. Journal of Drugs in Dermatology 15(5): 553-561, 2017

Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled Trials. Journal of Drugs in Dermatology 15(8): 962-969, 2017